Botulinum Toxin Injection for Treatment of Vaginismus
Comparison of Efficacy of 250 Units Versus 500 Units of Botulinum Toxin in the Treatment of Refractory Vaginismus
1 other identifier
interventional
40
1 country
1
Brief Summary
According to high rate of vaginismus (about 10 percent) which leads to unconsummated marriage (about 1 percent) and low efficacy for conventional treatments such as biofeedback therapy, analgesic drugs and pain killers and surgical treatment, there's necessity to find more effective method. In our previous study, injecting botulinum toxin in 23 patients cured 75% of them.Now we are to make comparison between different doses of toxin injection and record the patient sexual satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Oct 2007
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 10, 2008
CompletedFirst Posted
Study publicly available on registry
March 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedMarch 18, 2008
March 1, 2008
6 months
January 10, 2008
March 17, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
50 percent of patient satisfaction
first two month
Secondary Outcomes (1)
total patient satisfaction
next four month
Study Arms (2)
1
EXPERIMENTAL2
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Unconsummated marriage
- Difficult mating
- No response to biofeedback
You may not qualify if:
- Patient unlikely to have toxin injection
- Not having mutual life with partner
- Non treated pelvic and vaginal infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tehran University of Medical Sciences, Vali e Asr Reproductive Health Research Center
Tehran, Tehran Province, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abbas noroozi, PhD
Tehran University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 10, 2008
First Posted
March 18, 2008
Study Start
October 1, 2007
Primary Completion
April 1, 2008
Study Completion
April 1, 2008
Last Updated
March 18, 2008
Record last verified: 2008-03